168 related articles for article (PubMed ID: 31845738)
1. Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.
Schildkraut JM
Am J Epidemiol; 2020 Jul; 189(7):671-673. PubMed ID: 31845738
[TBL] [Abstract][Full Text] [Related]
2. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
Fu Z; Taylor S; Modugno F
Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
[TBL] [Abstract][Full Text] [Related]
3. Estimated Number of Lifetime Ovulatory Years and Its Determinants in Relation to Levels of Circulating Inflammatory Biomarkers.
Huang T; Shafrir AL; Eliassen AH; Rexrode KM; Tworoger SS
Am J Epidemiol; 2020 Jul; 189(7):660-670. PubMed ID: 31845729
[TBL] [Abstract][Full Text] [Related]
4. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
[TBL] [Abstract][Full Text] [Related]
5. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium.
Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS
Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430
[TBL] [Abstract][Full Text] [Related]
6. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
7. Invited Commentary: Women's Reproductive Life Spans and Subsequent Inflammatory Profiles-How to Best Measure Reproductive Life Span and the Need for Baseline Assessments.
Schliep KC
Am J Epidemiol; 2020 Jul; 189(7):674-676. PubMed ID: 31845720
[TBL] [Abstract][Full Text] [Related]
8. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
10. Lifetime ovulatory years and ovarian cancer gene expression profiles.
Sasamoto N; Stewart PA; Wang T; Yoder SJ; Chellappan S; Hecht JL; Fridley BL; Terry KL; Tworoger SS
J Ovarian Res; 2022 May; 15(1):59. PubMed ID: 35562768
[TBL] [Abstract][Full Text] [Related]
11. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
13. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G
J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528
[TBL] [Abstract][Full Text] [Related]
14. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
16. Invited commentary: dietary polyunsaturated Fatty acids and chronic systemic inflammation--a potentially intriguing link.
Chowdhury R; Steur M
Am J Epidemiol; 2015 Jun; 181(11):857-60. PubMed ID: 25899093
[TBL] [Abstract][Full Text] [Related]
17. Incessant ovulation and ovarian cancer: a critical approach.
La Vecchia C; Franceschi S; Gallus G; Decarli A; Liberati A; Tognoni G
Int J Epidemiol; 1983 Jun; 12(2):161-4. PubMed ID: 6874210
[TBL] [Abstract][Full Text] [Related]
18. Possible role of ovarian epithelial inflammation in ovarian cancer.
Ness RB; Cottreau C
J Natl Cancer Inst; 1999 Sep; 91(17):1459-67. PubMed ID: 10469746
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles.
Capobianco G; de Muro P; Cherchi GM; Formato M; Lepedda AJ; Cigliano A; Zinellu E; Dessole F; Gordini L; Dessole S
Arch Gynecol Obstet; 2010 Aug; 282(2):207-13. PubMed ID: 20306065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
